is compounded semaglutide going away – $149/mo FDA Warns Against Using Compounded
Description
Tirzepatide is a dual agonist that targets glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)
:max_bytes(150000):strip_icc()/HEALTH-DWL-frame-final-4-83ab587c91ea4eab9e89a0e86add8e41.jpg)
The TRIUMPH-1 Phase 3 trial showed participants losing up to 28.3% of their body weight at 80 weeks
Your gut motility drops
If you are curious about this approach, a medical consultation can determine whether Wegovy therapy fits your goals
